Related Experiment Video
Updated: Mar 28, 2026
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022
Emerging and investigational therapies for intraventricular hemorrhage in preterm infants
Simerdeep K Dhillon1, Michael J Beacom1, Victoria J King1
1Department of Physiology, The University of Auckland, Auckland, New Zealand.
Insights
Germinal matrix-intraventricular haemorrhage (GM-IVH) in premature infants causes significant brain injury. This review explores interventions targeting secondary injury cascades to mitigate neurotoxicity and hydrocephalus.
Area of Science:
- Neonatal neurology
- Neurocritical care
- Developmental neuroscience
Background:
- Germinal matrix-intraventricular haemorrhage (GM-IVH) is a severe complication in premature infants.
- GM-IVH leads to significant mortality and long-term neurodevelopmental deficits.
- Current treatments for established GM-IVH brain injury are lacking.
Purpose of the Study:
- To review evidence on secondary injury cascades triggered by GM-IVH.
- To explore potential therapeutic interventions for mitigating GM-IVH-induced brain injury.
- To evaluate the translational potential of these therapies for clinical application.
Main Methods:
- Literature review of studies investigating GM-IVH pathophysiology and treatment strategies.
- Analysis of evidence for acute interventions (clot clearance, CSF flow restoration).
- Examination of pharmacological and cellular therapies targeting secondary injury mechanisms.
Main Results:
- GM-IVH initiates a prolonged cascade of secondary events beyond initial tissue damage.
- Interventions targeting iron overload, oxidative stress, inflammation, and promoting neurorepair show promise.
- Acute interventions may improve outcomes by managing clot burden and CSF dynamics.
Conclusions:
- GM-IVH involves complex secondary injury pathways amenable to targeted therapies.
- Pharmacological and cellular strategies offer potential to mitigate neurotoxicity and prevent hydrocephalus.
- Further research and clinical trials are needed to translate these findings into effective treatments for premature infants.
Abstract:
Germinal matrix-intraventricular hemorrhage (GM-IVH) is a major complication of prematurity that contributes significantly to mortality and long-term neurodevelopmental impairments. There are no established treatments to reverse or directly treat the established brain injury resulting from IVH. This review examines the growing evidence that IVH is not simply local destruction of tissue, but that it also triggers a long-lasting cascade of secondary events that may be mitigated with targeted interventions. Strategies may include acute interventions to enhance clot clearance and restore cerebrospinal fluid flow, followed by pharmacological and cellular therapies to mitigate secondary neurotoxicity and the progression to post-haemorrhagic hydrocephalus, by targeting iron overload, oxidative stress, and inflammation, or promoting neurorepair. Finally, we critically evaluate the translational potential of these therapies and outline future directions for research and clinical application.
